Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.

J Transl Med · 2025 · PMC11755833 · PMID 39844178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Further analysis demonstrated that the proportion of SFL-TLS differed across TNM and T stages, with a higher proportion in stage III patients and a decreasing trend from T1 to T4 stages, indicating that both TNM and T stages may affect TLS maturity (sFigure 1D, H).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.